Quantcast

Latest chemotherapy Stories

2014-05-28 12:30:26

Surveyed U.S. Payers Are Most Receptive to Therapies Offering a Median Overall Survival Benefit over Current Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., May 28, 2014 /PRNewswire/ -- Decision Resources Group finds that, in addition to an improvement in median overall survival (MOS), delayed disease progression is one of the greatest unmet needs in the first-line treatment of chemotherapy-naive metastatic castrate-resistant prostate cancer (mCRPC). In this...

2014-05-28 08:51:16

University of Zurich DNA damage repair is highly complex. UZH researchers have now discovered another piece in the puzzle for the removal of extremely dangerous DNA lesions. Faithful and efficient repair of so-called crosslinks requires a collaboration between a specific signalling and repair protein. As crosslink-inducing agents are used in chemotherapy, the new insights are also important for the development of better anti-cancer treatment strategies. Environmental influences such as...

2014-05-28 08:33:09

LIVINGSTON, N.J., May 28, 2014 /PRNewswire/ -- The Silverstrom Group is proud to announce the first winner of the Smiles for Life Award in partnership with the American Cancer Society. Inspired to donate their medical expertise to help others, Dr. David Silverstrom and Dr. Gary Silverstrom's philanthropic award bestows a cosmetic dental makeover worth $25,000 to a cancer survivor in the New Jersey/New York area. After a long selection process, the dentists chose Betty Wetterauw of...

2014-05-28 04:24:21

LONDON and TORONTO, May 28, 2014 /PRNewswire/ -- ThioBridge(TM) linker to attach cytotoxic payloads to alpha fetoprotein PolyTherics Limited ("PolyTherics"), an Abzena company that provides technologies and services to enable the development of better biopharmaceuticals, today announced a collaboration with Alpha Cancer Technologies Inc. ("ACT"), a Canadian company with a targeted drug delivery platform based on alpha fetoprotein ("AFP"). PolyTherics will produce...

2014-05-27 04:21:49

MELBOURNE, Australia, May 27, 2014 /PRNewswire/ -- Expanded SAB will oversee development of EMA401, Company's lead program for treating chronic pain Spinifex Pharmaceuticals, a pain drug development company, today announces that three internationally acclaimed scientists in chronic pain research have joined the Company's Scientific Advisory Board (SAB). Their core research areas include understanding the basis for pain...

2014-05-27 04:20:05

Indication of Anticancer Agent Halaven for Use in Earlier-Line Treatment of Advanced Breast Cancer Tokyo, May 27, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that its U.K. subsidiary Eisai Europe Limited has received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) on the indication expansion...

2014-05-23 16:24:12

Vectibix is the First and Only Biologic to Offer Significant Survival Benefit as a First-Line Treatment with FOLFOX Chemotherapy for Patients with Wild-Type KRAS Metastatic Colorectal Cancer THOUSAND OAKS, Calif., May 23, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Vectibix(® )(panitumumab) for use in combination with FOLFOX, an oxaliplatin-based chemotherapy regimen, as first-line treatment in patients with...

2014-05-21 23:04:57

Transparency Market Research published a new report "Global Infusion Pumps Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/infusion-systems-market.html. Albany, New York (PRWEB) May 21, 2014 According to a new market report published by Transparency Market Research "Infusion Pumps Market (Large Volume, Disposable, Syringe, Ambulatory and Implantable) -...

2014-05-21 13:51:36

University of California - San Diego Tumor modeling predicts most effective drugs targeting brain cancer Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have used computer simulations of cancer cells – cancer avatars – to identify drugs most likely to kill cancer cells isolated from patients' brain tumors. The findings, published in May 21 online issue of the Journal of Translational Medicine, may help researchers stratify cancer...

2014-05-21 12:26:32

FECYT - Spanish Foundation for Science and Technology A possible pharmacology objective for chemotherapy Patients receiving chemical treatment for cancer often suffer fatigue and body weight loss, two of the most worrying effects of this therapy linked to the alteration of their circadian rhythms. The circadian system, better known as our biological clock, is responsible for coordinating all the processes that take place in our organism. If it does not function correctly, what is...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »
Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related